Lung Disease News and Research

RSS

Low birthweight babies have poor survival despite advances in neonatal care, study shows

A new study published in Acta Paediatrica indicates that survival of babies born weighing ≤500 g is poor despite advances in neonatal care.

27 Sep 2017

Self-management program with customized action plan results in better outcomes for COPD patients

The University of Twente carried out the first study worldwide that shows patients with COPD (lung disease caused by smoking) and other illnesses (heart disease, diabetes, anxiety and depression) have better outcomes if they follow a self-management program with a customized action plan. Anke Lenferink of UT recently obtained a doctoral degree on this subject.

27 Sep 2017

University of Portsmouth helping tackle air pollution in Sub-Saharan Africa

The University of Portsmouth is helping to tackle air pollution and its harmful effects in Sub-Saharan Africa.

22 Sep 2017

High-dose flu vaccine could protect middle-aged adults with chronic conditions

Expanding the high-dose influenza vaccine recommendation to include middle-aged adults with chronic health conditions may make economic sense and save lives, report scientists at the University of Pittsburgh School of Medicine.

21 Sep 2017

Study: 52-gene risk profile accurately predicts survival for patients with severe lung disease

An international Yale-led research team has shown that a risk profile based on 52 genes accurately predicts survival for patients with a severe lung disease. If confirmed in further studies, the finding could transform the way patients are treated for the condition, which is on the rise in older adults.

20 Sep 2017

Insmed reports top-line data from Phase 3 study of new treatment in patients with NTM lung disease

Insmed Incorporated, a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced top-line data from its Phase 3 CONVERT study.

13 Sep 2017

Antibody therapy found effective in subgroup of patients with treatment-resistant COPD

An antibody treatment reduces the rate of flare-ups by nearly 20 percent in patients with a subgroup of treatment-resistant chronic obstructive pulmonary disease (COPD), according to the results of two large international trials presented today at the European Respiratory Society International Congress in Milan, Italy, and simultaneously published in the New England Journal of Medicine.

12 Sep 2017

Nurses at risk of chronic lung disease COPD due to regular disinfectant use

According to a new study, nurses who are work disinfectants continually through their careers are more likely to develop a chronic lung disease called chronic obstructive pulmonary disease (COPD).

10 Sep 2017

Detailed understanding of ‘one of the most complex organs’ could provide new ways to treat lung disorders

Details of lung cell molecular pathways that promote or inhibit tissue regeneration were reported by researchers from the Perelmen School of Medicine at the University of Pennsylvania in Cell this week. Their aim is to find new ways to treat lung disorders.

7 Sep 2017

Study sheds light on virulence strategy of intracellular bacteria that cause legionellosis

Intracellular pathogens adopt various strategies to circumvent the defences of the host cell and to proliferate intracellularly. One specific strategy is to target host organelles like the mitochondria. Mitochondria are well-defined cytoplasmic organelles, which take part in a variety of cellular metabolic functions.

7 Sep 2017

Common heart disease medication may help treat pulmonary arterial hypertension

A team of Cleveland Clinic researchers found that a common heart disease medication, beta blockers, may help treat pulmonary arterial hypertension (PAH), a debilitating lung disease.

31 Aug 2017

Protein distribution channel may be new target for combating pathogenic bacterium

A bacterium that attacks people suffering from chronic lung disease and compromised immune systems could be halted by disrupting the distribution channels the organism uses to access the nutrient-rich cytoplasm of its host cell.

31 Aug 2017

Lung experts test nicotine patches as potential treatment for sarcoidosis

Doctors believe there is some good to be found in nicotine, the highly addictive drug in tobacco products. Lung experts at The Ohio State University Wexner Medical Center are testing whether nicotine can help people with a chronic inflammatory lung disease called sarcoidosis.

28 Aug 2017

Medical care in California's NICUs influenced by infants' racial and ethnic identities

Infants' racial and ethnic identities influence the quality of medical care they receive in California's neonatal intensive care units, a study from the Stanford University School of Medicine has found.

28 Aug 2017

SLU-led project receives NIH funding for clinical trial on potential treatment for MDR-TB

Saint Louis University is leading a multi-national clinical trial of what could become a regimen for drug resistant tuberculosis (TB) that does not require injectable medications. The project is funded by a $6.4 million task order from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

26 Aug 2017

Study reveals link between vitamin B supplementation and lung cancer

A new study has shown that taking high-dose vitamin B supplements over a long period is associated with an increased risk of lung cancer among men.

23 Aug 2017

Exoskeleton device helps man with disabling condition to complete 10K race

Martin Jarry was a police officer in Quebec. He coached a youth hockey team. He was used to being active, used to working out, used to being strong. But when Jarry was diagnosed with inclusion body myositis (IBM), he had to do some serious re-evaluating of his activities.

10 Aug 2017

New clinical trial examines potential role of drug combination therapy to eliminate LAM cells

Researchers at the University of Cincinnati begin a new clinical trial this fall, examining the potential role of a drug combination therapy to eliminate lymphangioleiomyomatosis (LAM) cells.

7 Aug 2017

Under Trump, hospitals face same penalties embraced by Obama

Amid all the turbulence over the future of the Affordable Care Act, one facet continues unchanged: President Donald Trump's administration is penalizing more than half the nation's hospitals for having too many patients return within a month.

3 Aug 2017

Researchers develop potential stem cell treatment for several lung conditions

A team of scientists from the UNC School of Medicine and North Carolina State University has developed promising research towards a possible stem cell treatment for several lung conditions, such as idiopathic pulmonary fibrosis (IPF), chronic obstructive pulmonary disease (COPD), and cystic fibrosis -- often-fatal conditions that affect tens of millions of Americans.